Daptomycin Resistance in Clinical MRSA Strains Is Associated with a High Biological Fitness Cost

Daptomycin remains as one of the main treatment options for Methicillin-Resistant Staphylococcus aureus (MRSA). Sporadic resistance cases reported in patients treated with either daptomycin or glycopeptides are a growing concern. In a previous study, we described a clinical case of a patient with a...

Descripción completa

Detalles Bibliográficos
Autores principales: Roch, Melanie, Gagetti, Paula, Davis, James, Ceriana, Paola, Errecalde, Laura, Corso, Alejandra, Rosato, Adriana E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2017
Materias:
Microbiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5723333/
https://www.ncbi.nlm.nih.gov/pubmed/29259579
http://dx.doi.org/10.3389/fmicb.2017.02303

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5723333/
https://www.ncbi.nlm.nih.gov/pubmed/29259579
http://dx.doi.org/10.3389/fmicb.2017.02303

Ejemplares similares